Human umbilical cord blood-derived mononuclear cell transplantation: Case series of 30 subjects with Hereditary Ataxia

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Yang, Wan Zhang ^a   Zhang, Yun ^b   Wu, Fang ^a   Zhang, Min ^a   Cho, SC ^c   Li, Chun Zhen ^a   Li, Shao Hui ^a   Shu, Guo Jian ^a   Sheng, You Xiang ^a   Zhao, Ning ^a   Tang, Ying ^a   Jiang, Shu ^b   Jiang, Shan ^b   Gandjian, Matthew ^d   Ichim, Thomas E ^d   Hu, Xiang ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Shenzhen Beike Cell Engineering Research Institute   (China)

^c STANFORD UNIVERSITY   (United States)

^d Medistem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; BERG BALANCE SCALE; CASE STUDY; CD3+ CD4 T LYMPHOCYTE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; HEREDITARY ATAXIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NEUROMUSCULAR FACILITATION; OPEN STUDY; PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION; RATING SCALE; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD DERIVED MONONUCLEAR CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; SPINOCEREBELLAR DEGENERATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SPINOCEREBELLAR DEGENERATIONS; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955891374     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-65     Document Type: Article

References (34)

1. Wang WZ, Luo ZM. Neurology. Beijing: The People's Medical Publishing House 2004, 286-290. 5.
2. Furtado S, Das Sand Suchowersky O. A review of the inherited ataxias: recent advances in genetic, clinical and neuropathologic aspects. Parkinsonism and Related Disorders 1998, 4:161-169. 10.1016/S1353-8020(98)00030-3, 18591106.
3. Schmitz-Hübsch T, Klockgether T. An update on inherited ataxias. Current Neurology and Neuroscience Reports 2008, 8:310-319. 10.1007/s11910-008-0048-4, 18590615.
4. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007, 6:245-257. 10.1016/S1474-4422(07)70054-6, 17303531.
5. Brusse E, Maat-Kievit JA, Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007, 71:12-24. 10.1111/j.1399-0004.2006.00722.x, 17204042.
6. Mancuso M, Orsucci D, Choub A, Siciliano G. Current and emerging treatment options in the management of Friedreich ataxia. Neuropsychiatric Disease and Treatment 2010, 6:491-499. 10.2147/NDT.S6916, 2938298, 20856912.
7. Santos R, Lefevre S, Sliwa D, Seguin A. Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities. Antioxid Redox Signal 2010, 13:651-690. 10.1089/ars.2009.3015, 20156111.
8. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, Bresolin N, Comi GP, Corti S. Stem cell therapy in stroke. Cell Mol Life Sci 2009, 66:757-772. 10.1007/s00018-008-8346-1, 18989624.
9. Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun LY. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Multiple Sclerosis 2009, 15:644-646. 10.1177/1352458509104590, 19389752.
10. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009, 11(1):26-34. 10.1080/14653240802644651, 19191058.
11. Roberts TJ, Price J, Williams SC, Modo M. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 2006, 139:1187-1199. 10.1016/j.neuroscience.2006.01.025, 16517087.
12. Redmond DE, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR, Sidman RL, Snyder EY. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci 2007, 104:12175-12180. 10.1073/pnas.0704091104, 1896134, 17586681.
13. Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, Ronchi D, Saladino F, Bordoni A, Fortunato F, Del BR, Papadimitriou D, Locatelli F, Menozzi G, Strazzer S, Bresolin N, Comi GP. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J Clin Invest 2008, 118:3316-3330. 10.1172/JCI35432, 2525699, 18769634.
14. Jones J, Jaramillo-Merchán J, Bueno C, Pastor D, Viso-León M, Martínez S. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis 2010, 40(2):415-423. 10.1016/j.nbd.2010.07.001, 20638477.
15. Chintawar S, Hourez R, Ravella A, Gall D, Orduz D, Rai M, Bishop DP, Geuna S, Schiffmann SN, Pandolfo M. Grafting neural precursor cells promotes functional recovery in a SCA1 mouse model. J Neurosci 2009, 29(42):13126-13135. 10.1523/JNEUROSCI.0647-09.2009, 19846700.
16. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. Journal of Translational Medicine 2010, 8:75-80. 10.1186/1479-5876-8-75, 2922090, 20682053.
17. Zhang JW, Guo SG, Wang CJ, Sun T, Wang TH. Treatment of cerebellar ataxia by neural stem cell transplantation. Journal of Medical Forum 2010, 31(18):19-20.
18. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, Miller C, Rossi R, Sanberg PR. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One 2008, 3(6):e2494. 10.1371/journal.pone.0002494, 2429976, 18575617.
19. Park DH, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, Chung YG, Sanberg PR. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant 2009, 18(9):985-998. 10.3727/096368909X471279, 19523333.
20. Javed MJ, Mead LE, Prater D, Bessler WK, Foster D, Case J, Goebel WS, Yoder MC, Haneline LS, Ingram DA. Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood. Pediatr Res 2008, 64:68-73. 10.1203/PDR.0b013e31817445e9, 18360305.
21. Yelnik A, Bonan I. Clinical tools for assessing balance disorders. Neurophysiol Clin 2008, 38(6):439-445. 10.1016/j.neucli.2008.09.008, 19026963.
22. Chen L, Jiang Z, Huang HY, Zhang F, Liu YC, Xi HT, Wang HM, Ren YS, Zhou CM. Preliminary Result of Olfactory Ensheathing Cell Transplantation in Intractable Neuropathic Pain Following Spinal Cord Injury: 17 Cases Report. Chinese Journal of Rehabilitation Theory and Practice 2010, 16(2):146-148.
23. Zhang RY, Zheng YR, Hu SS, Cheng HB, An YH. Clinical analysis of neural stem cells for treatment of sequela in 50 stroke patients. Chinese Journal of Clinical Rehabilitation 2006, 20(9):138-139.
24. Riordan NH, Chan K, Marleau AM, Ichim TE. Cord blood in regenerative medicine: do we need immune suppression?. J Transl Med 2007, 5:8. 10.1186/1479-5876-5-8, 1796850, 17261200.
25. Yang WZ, Wu F, Zhang M, Yang JY, Liang HM, Sheng YX, Hu X, Zhao N, Yang ZG, Tang Y. Cord Blood-derived Neural Stem Cell Transplantation in Nervous System Diseases. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2009, 7(3):287-290.
26. Yang WZ, Yang JY, Liang HM, Zhang M, Wu F, Sheng FX, Yang ZG, Tang Y, Zhao N, Hu X, Jiang S, Guo SQ. Efficacy and Safety of Cord Blood Source Neural Stem Cell for Amyotrophic Lateral Sclerosis. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2007, 5(10):911-913.
27. Zhang M, Yang WZ, Sheng YX, Wu F, Liang HM, Zhao N, Hu X, Jiang S, Guo SQ. Clinical Efficacy and Safety of Transplantation of Umbilical Cord Blood Source Neural Stem Cells for Multiple Sclerosis. Practical Preventive Medicine 2008, 15(4):1186-1188.
28. Newcomb JD, Sanberg PR, Klasko SK, Willing AE. Umbilical cord blood research: current and future perspectives. Cell Transplant 2007, 16(2):151-158. 2720821, 17474296.
29. Arien-Zakay H, Lecht S, Bercu MM, Tabakman R, Kohen R, Galski H, Nagler A, Lazarovici P. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol 2009, 216(1):83-94. 10.1016/j.expneurol.2008.11.006, 19070617.
30. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE. Infusion of Human Umbilical Cord Blood Cells in a Rat Model of Stroke Dose-Dependently Rescues Behavioral Deficits and Reduces Infarct Volume. Stroke 2004, 35:2390-2395. 10.1161/01.STR.0000141681.06735.9b, 15322304.
31. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats. Stroke 2001, 32:2682-2688. 10.1161/hs1101.098367, 11692034.
32. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003, 12(3):255-270. 10.1089/152581603322022990, 12857367.
33. Park DH, Lee JH, Borlongan CV, Sanberg PR, Chung YG, Cho TH. Transplantation of Umbilical Cord Blood Stem Cells for Treating Spinal Cord Injury. Stem Cell Rev 2011, 7(1):181-194. 10.1007/s12015-010-9163-0, 20532836.
34. Dasari VR, Spomar DG, Gondi CS, Sloffer CA, Saving KL, Gujrati M, Rao JS, Dinh DH. Axonal Remyelination by Cord Blood Stem Cells after Spinal Cord Injury. J Neurotrauma 2007, 24(2):391-410. 10.1089/neu.2006.0142, 1859845, 17376002.